MX2016007902A - Composiciones y metodos para el tratamiento del glaucoma. - Google Patents
Composiciones y metodos para el tratamiento del glaucoma.Info
- Publication number
- MX2016007902A MX2016007902A MX2016007902A MX2016007902A MX2016007902A MX 2016007902 A MX2016007902 A MX 2016007902A MX 2016007902 A MX2016007902 A MX 2016007902A MX 2016007902 A MX2016007902 A MX 2016007902A MX 2016007902 A MX2016007902 A MX 2016007902A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- glaucoma
- treatment
- dexmedetomidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención proporciona composiciones del agonista del receptor adrenérgico a-2 y métodos para tratar el glaucoma y otras condiciones intraoculares. El agonista a-2 preferido utilizado en las composiciones y métodos de la invención es la dexmedetomidina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/132,780 US20140107173A1 (en) | 2011-02-03 | 2013-12-18 | Compositions and Methods for Treatment of Glaucoma |
PCT/US2014/015797 WO2015094392A1 (en) | 2013-12-18 | 2014-02-11 | Compositions and methods for treatment of glaucoma |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016007902A true MX2016007902A (es) | 2016-10-28 |
Family
ID=53403464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016007902A MX2016007902A (es) | 2013-12-18 | 2014-02-11 | Composiciones y metodos para el tratamiento del glaucoma. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP3082427A4 (es) |
JP (1) | JP2017501224A (es) |
CN (1) | CN106455567A (es) |
BR (1) | BR112016014404A2 (es) |
CA (1) | CA2934453A1 (es) |
MX (1) | MX2016007902A (es) |
WO (1) | WO2015094392A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3429584A4 (en) * | 2016-03-17 | 2019-11-13 | Presbyopia Therapies, LLC | COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA |
CN111481506B (zh) * | 2019-01-25 | 2023-01-24 | 江苏恒瑞医药股份有限公司 | 一种包含经鼻给药的右美托咪定组合物的药物制品 |
CN112107544A (zh) * | 2019-06-28 | 2020-12-22 | 四川普锐特药业有限公司 | 右美托咪定鼻喷剂、其制备方法及应用 |
CN112138250B (zh) * | 2019-06-28 | 2023-04-14 | 四川普锐特药业有限公司 | 保持给药均一度的药物流体分配器及右美托咪定鼻喷器 |
CN111632025A (zh) * | 2020-03-04 | 2020-09-08 | 吉林大学第一医院 | 一种贝美前列素眼用温度敏感型原位凝胶及其制备方法与应用 |
CN115137699B (zh) * | 2021-03-29 | 2024-05-03 | 四川普锐特药业有限公司 | 一种增效防腐的右美托咪定鼻喷剂 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2290964A (en) * | 1994-07-08 | 1996-01-17 | Arto Olavi Urtti | Transdermal drug delivery system |
WO2005014046A2 (en) * | 2003-08-07 | 2005-02-17 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes and methods for making and using the same |
DK2320911T3 (da) * | 2008-08-01 | 2014-11-03 | Eye Therapies Llc | Vasokonstriktionspræparater og fremgangsmåder til anvendelse deraf |
US20100202979A1 (en) * | 2008-08-01 | 2010-08-12 | Gerald Horn | Compositions and methods for treatment of pulmonary diseases and conditions |
CA2782872A1 (en) * | 2009-12-17 | 2011-06-23 | Alpha Synergy Development, Inc. | Compositions and methods for ophthalmic delivery of nasal decongestants |
US20110189174A1 (en) * | 2010-02-01 | 2011-08-04 | Afshin Shafiee | Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
EP2555748A2 (en) * | 2010-04-07 | 2013-02-13 | Allergan, Inc. | Combinations of preservatives for ophthalmic compositions |
US20120202863A1 (en) * | 2011-02-03 | 2012-08-09 | Gerald Horn | Compositions and methods for treatment of glaucoma |
US20140107173A1 (en) * | 2011-02-03 | 2014-04-17 | Gnt, Llc | Compositions and Methods for Treatment of Glaucoma |
US20130172357A1 (en) * | 2011-02-03 | 2013-07-04 | Eye Therapies Llc | Compositions and Methods for Treatment of Glaucoma |
BR112014000876A2 (pt) * | 2011-07-14 | 2017-02-21 | Allergan Inc | composições em gel de oximetazolina e métodos de uso |
US8242158B1 (en) * | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
CA2863760A1 (en) * | 2012-02-02 | 2013-08-08 | Alpha Synergy Development, Inc. | Compositions and methods for treatment of glaucoma |
US20140378401A1 (en) * | 2013-06-21 | 2014-12-25 | Gnt, Llc | Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations |
US9089562B2 (en) * | 2013-08-28 | 2015-07-28 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
-
2014
- 2014-02-11 WO PCT/US2014/015797 patent/WO2015094392A1/en active Application Filing
- 2014-02-11 MX MX2016007902A patent/MX2016007902A/es unknown
- 2014-02-11 BR BR112016014404A patent/BR112016014404A2/pt not_active IP Right Cessation
- 2014-02-11 EP EP14872240.8A patent/EP3082427A4/en not_active Withdrawn
- 2014-02-11 CA CA2934453A patent/CA2934453A1/en not_active Abandoned
- 2014-02-11 CN CN201480075789.5A patent/CN106455567A/zh active Pending
- 2014-02-11 JP JP2016560613A patent/JP2017501224A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2017501224A (ja) | 2017-01-12 |
BR112016014404A2 (pt) | 2017-08-08 |
EP3082427A4 (en) | 2017-08-02 |
CA2934453A1 (en) | 2015-06-25 |
EP3082427A1 (en) | 2016-10-26 |
WO2015094392A1 (en) | 2015-06-25 |
CN106455567A (zh) | 2017-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
NZ731467A (en) | Anti-tim3 antibodies and methods of use | |
PH12020500255A1 (en) | Use of nk-1 receptor antagonist serlopitant in pruritus | |
MX2019005192A (es) | Compuestos de quinolina selectivamente sustituida. | |
MX2021008376A (es) | Cultivo, produccion, procesamiento y uso de cannabis de especialidad. | |
MX2016015862A (es) | Compuestos inhibidores de la cinasa de union a tank. | |
NZ720769A (en) | Anti-siglec-8 antibodies and methods of use thereof | |
MX2016007902A (es) | Composiciones y metodos para el tratamiento del glaucoma. | |
MX2016013280A (es) | Composiciones topicas para el alivio del dolor, manufactura y uso. | |
MX2023006706A (es) | Administracion transdermica de agentes grandes en composiciones de emulsion mediante acondicionamiento de la piel con microagujas y sus usos. | |
MX2017002374A (es) | Composiciones y metodos para tratar trastornos de la vision. | |
MY186271A (en) | Ophthalmic compositions and methods of use therefor | |
MX2018006700A (es) | Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4). | |
MX2020000367A (es) | Inhibidores de rad51. | |
MX2020002216A (es) | Metodos y composiciones para detectar y tratar endometriosis. | |
MX2020004666A (es) | Compuestos de pilocarpina con ácido lipoico para el tratamiento de trastornos oculares. | |
MX2017006019A (es) | Apilimod para uso en el tratamiento de melanoma. | |
MX2016009312A (es) | Composiciones y metodos para el tratamiento de la neovascularizacion y/o fuga intraocular. | |
EP3226972A4 (en) | Methods and compositions for treating migraine and conditions associated with pain | |
EA201491894A1 (ru) | Способы лечения непереносимости лактозы | |
MX2016008150A (es) | Formulaciones de berberina y usos de las mismas. | |
TW201612160A (en) | Compounds as CRTH2 antagonist and uses thereof | |
MX2016009655A (es) | Metodos novedosos para el tratamiento del cancer. | |
PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
IL271211B1 (en) | Acetyl leucine for use in the treatment of migraine |